Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Not Yet Recruiting

Becotatug Vedotin Combined With Pucotenlimab as Neoadjuvant Therapy for Resectable Recurrent Head and Neck Squamous Cell Carcinoma After Progression on Immunotherapy: A Prospective Phase II Study

NCT07589049

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • The First People's Hospital of Foshan Foshan, Guangdong, China
  • Cancer Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • Guangzhou First People's Hospital Guangzhou, Guangdong, China
View Trial Details
Not Yet Recruiting

H&N NEO-COMBAT XL: Neoadjuvant XL-092 (Zanzalintinib) and Pembrolizumab (Keytruda) in Surgically Resectable, HPV Negative Oral Cavity Squamous Cell Carcinoma (OCSCC)

NCT07484139

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Emory University Atlanta, Georgia, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions